Hugo Hämmerle
Fundador en Tissue Engineering Technologies AG .
Perfil
Hugo Hämmerle is the founder of Tissue Engineering Technologies AG.
He currently holds the position of Deputy Chairman-Supervisory Board at Retina Implant AG, Director-Natural & Medical Science Institute at Eberhard Karls Universität Tübingen since 2012, and Managing Director at NMI Technologietransfer GmbH.
Previously, he served as a Member-Supervisory Board at STRATEC SE from 1990 to 2014.
Dr. Hämmerle obtained his doctorate degree from Eberhard Karls Universität Tübingen in 1987 and his undergraduate degree from the University of Hohenheim in 1982.
Cargos activos de Hugo Hämmerle
| Empresas | Cargo | Inicio |
|---|---|---|
Tissue Engineering Technologies AG
 Tissue Engineering Technologies AG BiotechnologyHealth Technology Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids and analogous products. The private company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. | Fundador | - |
Retina Implant AG
 Retina Implant AG Medical SpecialtiesHealth Technology Retina Implant AG develops sub retinal implants for partially sighted and blind patients. The company was founded in 2003 and is headquartered in Reutlingen, Germany. | Director/Miembro de la Junta | - |
| Eberhard Karls Universität Tübingen | Corporate Officer/Principal | - |
NMI Technologietransfer GmbH
 NMI Technologietransfer GmbH Miscellaneous Commercial ServicesCommercial Services Part of NMI Naturwissenschaftliches & Medizinisches Institut, NMI Technologietransfer GmbH is a contract research organization that consists of three business units: NMI TT Pharmaservices, NMI TT Testing Services, and NMI TT Microdevices. The company is based in Reutlingen, Germany. NMI TT Pharmaservices offers advanced cell-based assays, novel and better cell models, and custom cell lines for the pharma industry, oncology, academia, and cancer research. Additionally, the German company offers electrophysiology services on different target systems such as heart, brain, and retina. The CEO of the company is Hugo Hämmerle. | Director Ejecutivo | - |
Antiguos cargos conocidos de Hugo Hämmerle.
| Empresas | Cargo | Fin |
|---|---|---|
| STRATEC SE | Director/Miembro de la Junta | 18/06/2014 |
Formación de Hugo Hämmerle.
| University of Hohenheim | Undergraduate Degree |
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| STRATEC SE | Health Technology |
| Empresas privadas | 3 |
|---|---|
Tissue Engineering Technologies AG
Tissue Engineering Technologies AG BiotechnologyHealth Technology Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids and analogous products. The private company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. | Health Technology |
Retina Implant AG
Retina Implant AG Medical SpecialtiesHealth Technology Retina Implant AG develops sub retinal implants for partially sighted and blind patients. The company was founded in 2003 and is headquartered in Reutlingen, Germany. | Health Technology |
NMI Technologietransfer GmbH
NMI Technologietransfer GmbH Miscellaneous Commercial ServicesCommercial Services Part of NMI Naturwissenschaftliches & Medizinisches Institut, NMI Technologietransfer GmbH is a contract research organization that consists of three business units: NMI TT Pharmaservices, NMI TT Testing Services, and NMI TT Microdevices. The company is based in Reutlingen, Germany. NMI TT Pharmaservices offers advanced cell-based assays, novel and better cell models, and custom cell lines for the pharma industry, oncology, academia, and cancer research. Additionally, the German company offers electrophysiology services on different target systems such as heart, brain, and retina. The CEO of the company is Hugo Hämmerle. | Commercial Services |
- Bolsa de valores
- Insiders
- Hugo Hämmerle
